Antimicrobial Resistance: Current Status and Future Directions (Second Edition)

Dear Colleagues,

This Special Issue is the continuation of our 2024 Special Issue “Antimicrobial Resistance: Current Status and Future Directions”.

Resistance to antimicrobial drugs and the emergence of multi-resistant bacterial and fungal strains represent a problem of significant clinical relevance that poses serious threats to public health worldwide. The currently available data have shown a significant increase in drug resistance rates due to bacterial and fungal pathogens that are responsible for nosocomial and community infections worldwide. This leads to the reduced effectiveness of conventional drugs and consequently an increase in mortality rates. The World Health Organization (WHO) has underlined the fact that they consider epidemiological surveillance an essential factor in the control and management of the antimicrobial resistance problem. In addition, the WHO has also highlighted the importance of researching new classes of antimicrobial drugs to implement currently available drugs.

This Special Issue covers all aspects contributing to the resolution of the antimicrobial resistance phenomenon, i.e., epidemiological surveillance and all of the aspects of the discovery of new therapeutic options for multidrug-resistant infections, which include nanomaterials, natural and synthetic compounds, repurposed drugs, and existing drugs modified to treat multidrug-resistant infections. We invite researchers to contribute original research and review articles to this Special Issue.

Dr. Veronica Folliero
Dr. Federica Dell’Annunziata
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antimicrobial resistance
• bacteria
• fungi
• epidemiology
• infection
• antibiotics
• antifungal drugs
• surveillance
• drug discovery